Investment Analysts’ price target changes for Thursday, August 10th:

Koninklijke Ahold Delhaize NV (AMS:AD) was given a €21.00 ($24.71) price target by analysts at Morgan Stanley. The firm currently has a buy rating on the stock.

Koninklijke Ahold Delhaize NV (AMS:AD) was given a €19.50 ($22.94) price target by analysts at Deutsche Bank AG. The firm currently has a neutral rating on the stock.

Koninklijke Ahold Delhaize NV (AMS:AD) was given a €20.00 ($23.53) target price by analysts at J P Morgan Chase & Co. The firm currently has a buy rating on the stock.

ADTRAN (NASDAQ:ADTN) had its price target increased by Needham & Company LLC from $25.00 to $26.00. They currently have a buy rating on the stock.

Agios Pharmaceuticals (NASDAQ:AGIO) had its price target boosted by Needham & Company LLC from $54.00 to $72.00. The firm currently has a buy rating on the stock.

SLM Solutions Group AG (ETR:AM3D) was given a €24.00 ($28.24) price target by analysts at Commerzbank Ag. The firm currently has a sell rating on the stock.

Aareal Bank AG (ETR:ARL) was given a €39.00 ($45.88) price target by analysts at Independent Research GmbH. The firm currently has a neutral rating on the stock.

Aareal Bank AG (ETR:ARL) was given a €41.90 ($49.29) price target by analysts at Warburg Research. The firm currently has a buy rating on the stock.

Asterias Biotherapeutics (NYSE:AST) was given a $12.00 target price by analysts at HC Wainwright. The firm currently has a buy rating on the stock.

Barclays PLC (LON:BARC) was given a GBX 240 ($3.13) target price by analysts at J P Morgan Chase & Co. The firm currently has a buy rating on the stock.

BioDelivery Sciences International (NASDAQ:BDSI) was given a $5.00 target price by analysts at HC Wainwright. The firm currently has a buy rating on the stock.

BP plc (LON:BP) was given a GBX 525 ($6.84) price target by analysts at UBS AG. The firm currently has a buy rating on the stock.

BT Group plc (LON:BT.A) was given a GBX 290 ($3.78) target price by analysts at J P Morgan Chase & Co. The firm currently has a neutral rating on the stock.

Can Fite Biopharma (NASDAQ:CANF) was given a $6.00 price target by analysts at HC Wainwright. The firm currently has a buy rating on the stock.

Chicago Bridge & Iron Company N.V. (NYSE:CBI) was given a $10.00 price target by analysts at Robert W. Baird. The firm currently has a hold rating on the stock.

Cineworld Group plc (LON:CINE) had its target price increased by Canaccord Genuity from GBX 630 ($8.20) to GBX 700 ($9.12). They currently have a hold rating on the stock.

Capstone Turbine Corporation (NASDAQ:CPST) was given a $2.00 price target by analysts at HC Wainwright. The firm currently has a buy rating on the stock.

CorMedix (NYSEMKT:CRMD) had its price target trimmed by Rodman & Renshaw from $5.00 to $3.00. Rodman & Renshaw currently has a buy rating on the stock.

CorMedix (NYSEMKT:CRMD) was given a $3.00 price target by analysts at HC Wainwright. The firm currently has a buy rating on the stock.

CUI Global (NASDAQ:CUI) was given a $12.00 target price by analysts at HC Wainwright. The firm currently has a buy rating on the stock.

CEWE Stiftung & Co KGaA (ETR:CWC) was given a €92.00 ($108.24) price target by analysts at Warburg Research. The firm currently has a buy rating on the stock.

CytoDyn (NASDAQ:CYDY) was given a $2.00 target price by analysts at HC Wainwright. The firm currently has a buy rating on the stock.

Drillisch AG (ETR:DRI) was given a €64.00 ($75.29) price target by analysts at Kepler Capital Markets. The firm currently has a buy rating on the stock.

Drillisch AG (ETR:DRI) was given a €68.00 ($80.00) price target by analysts at UBS AG. The firm currently has a buy rating on the stock.

Drillisch AG (ETR:DRI) was given a €62.00 ($72.94) target price by analysts at Jefferies Group LLC. The firm currently has a neutral rating on the stock.

Drillisch AG (ETR:DRI) was given a €72.00 ($84.71) price target by analysts at Warburg Research. The firm currently has a buy rating on the stock.

E.On Se (FRA:EOAN) was given a €9.50 ($11.18) target price by analysts at J P Morgan Chase & Co. The firm currently has a buy rating on the stock.

Fortress Biotech (NASDAQ:FBIO) was given a $11.00 target price by analysts at HC Wainwright. The firm currently has a buy rating on the stock.

Amicus Therapeutics (NASDAQ:FOLD) had its target price raised by Chardan Capital from $12.50 to $17.50. Chardan Capital currently has a buy rating on the stock.

Glencore PLC (LON:GLEN) was given a GBX 350 ($4.56) price target by analysts at UBS AG. The firm currently has a buy rating on the stock.

Heidelberger Druckmaschinen AG (ETR:HDD) was given a €3.60 ($4.24) target price by analysts at Warburg Research. The firm currently has a buy rating on the stock.

Henkel AG & Co KGaA (FRA:HEN3) was given a €135.00 ($158.82) target price by analysts at Warburg Research. The firm currently has a buy rating on the stock.

Henkel AG & Co KGaA (FRA:HEN3) was given a €113.00 ($132.94) target price by analysts at UBS AG. The firm currently has a sell rating on the stock.

Henkel AG & Co KGaA (FRA:HEN3) was given a €133.00 ($156.47) target price by analysts at Kepler Capital Markets. The firm currently has a buy rating on the stock.

Henkel AG & Co KGaA (FRA:HEN3) was given a €114.00 ($134.12) price target by analysts at Nord/LB. The firm currently has a neutral rating on the stock.

Hella Kgaa Hueck & Co (ETR:HLE) was given a €46.00 ($54.12) target price by analysts at Nord/LB. The firm currently has a neutral rating on the stock.

Hella Kgaa Hueck & Co (ETR:HLE) was given a €47.00 ($55.29) price target by analysts at UBS AG. The firm currently has a buy rating on the stock.

Hannover Rueck SE (FRA:HNR1) was given a €109.00 ($128.24) price target by analysts at UBS AG. The firm currently has a neutral rating on the stock.

Hannover Rueck SE (FRA:HNR1) was given a €121.00 ($142.35) price target by analysts at Kepler Capital Markets. The firm currently has a buy rating on the stock.

HSBC Holdings plc (LON:HSBA) was given a GBX 690 ($8.99) target price by analysts at J P Morgan Chase & Co. The firm currently has a neutral rating on the stock.

Jenoptik AG (ETR:JEN) was given a €22.50 ($26.47) target price by analysts at Independent Research GmbH. The firm currently has a sell rating on the stock.

The KEYW Holding Corporation (NASDAQ:KEYW) was given a $13.00 price target by analysts at Maxim Group. The firm currently has a buy rating on the stock.

LEG Immobilien AG (FRA:LEG) was given a €100.00 ($117.65) price target by analysts at Kepler Capital Markets. The firm currently has a buy rating on the stock.

Leoni Ag (ETR:LEO) was given a €55.00 ($64.71) target price by analysts at Independent Research GmbH. The firm currently has a neutral rating on the stock.

Leoni Ag (ETR:LEO) was given a €50.00 ($58.82) target price by analysts at J P Morgan Chase & Co. The firm currently has a neutral rating on the stock.

Lloyds Banking Group PLC (LON:LLOY) was given a GBX 83 ($1.08) price target by analysts at J P Morgan Chase & Co. The firm currently has a buy rating on the stock.

Lanxess AG (ETR:LXS) was given a €72.00 ($84.71) price target by analysts at Independent Research GmbH. The firm currently has a neutral rating on the stock.

Lanxess AG (ETR:LXS) was given a €68.00 ($80.00) price target by analysts at UBS AG. The firm currently has a neutral rating on the stock.

Lanxess AG (ETR:LXS) was given a €87.00 ($102.35) target price by analysts at Kepler Capital Markets. The firm currently has a buy rating on the stock.

Magic Software Enterprises (NASDAQ:MGIC) was given a $10.00 price target by analysts at HC Wainwright. The firm currently has a buy rating on the stock.

Nabors Industries (NYSE:NBR) was given a $9.00 target price by analysts at Credit Suisse Group. The firm currently has a buy rating on the stock. They noted that the move was a valuation call. The analysts noted that the move was a valuation call.

Aurubis AG (ETR:NDA) was given a €84.00 ($98.82) price target by analysts at Warburg Research. The firm currently has a buy rating on the stock.

Protalix Biotherapeutics (NYSEMKT:PLX) was given a $5.00 price target by analysts at HC Wainwright. The firm currently has a buy rating on the stock.

Portola Pharmaceuticals (NASDAQ:PTLA) was given a $70.00 price target by analysts at Credit Suisse Group. The firm currently has a hold rating on the stock. They noted that the move was a valuation call. The analysts noted that the move was a valuation call.

SMA Solar Technology AG (ETR:S92) was given a €20.00 ($23.53) price target by analysts at Warburg Research. The firm currently has a sell rating on the stock.

Stroeer SE & Co KGaA (ETR:SAX) was given a €64.00 ($75.29) target price by analysts at Commerzbank Ag. The firm currently has a buy rating on the stock.

Stroeer SE & Co KGaA (ETR:SAX) was given a €56.50 ($66.47) target price by analysts at Kepler Capital Markets. The firm currently has a buy rating on the stock.

SAF-HOLLAND (ETR:SFQ) was given a €18.50 ($21.76) target price by analysts at Kepler Capital Markets. The firm currently has a buy rating on the stock.

SAF-HOLLAND (ETR:SFQ) was given a €17.00 ($20.00) price target by analysts at equinet AG. The firm currently has a buy rating on the stock.

SAF-HOLLAND (ETR:SFQ) was given a €19.00 ($22.35) target price by analysts at Warburg Research. The firm currently has a buy rating on the stock.

Sangamo Therapeutics (NASDAQ:SGMO) was given a $8.00 price target by analysts at Piper Jaffray Companies. The firm currently has a hold rating on the stock.

Synergy Pharmaceuticals (NASDAQ:SGYP) had its target price lowered by Rodman & Renshaw from $18.00 to $15.00. Rodman & Renshaw currently has a buy rating on the stock.

Siemens AG (FRA:SIE) was given a €131.00 ($154.12) price target by analysts at UBS AG. The firm currently has a buy rating on the stock.

Symrise AG (FRA:SY1) was given a €60.00 ($70.59) target price by analysts at J P Morgan Chase & Co. The firm currently has a neutral rating on the stock.

Salzgitter AG (ETR:SZG) was given a €38.00 ($44.71) price target by analysts at Commerzbank Ag. The firm currently has a neutral rating on the stock.

ThyssenKrupp AG (FRA:TKA) was given a €26.00 ($30.59) price target by analysts at Kepler Capital Markets. The firm currently has a neutral rating on the stock.

ThyssenKrupp AG (FRA:TKA) was given a €20.50 ($24.12) target price by analysts at UBS AG. The firm currently has a sell rating on the stock.

ThyssenKrupp AG (FRA:TKA) was given a €27.00 ($31.76) price target by analysts at Independent Research GmbH. The firm currently has a neutral rating on the stock.

TOM TAILOR Holding AG (ETR:TTI) was given a €10.00 ($11.76) price target by analysts at Commerzbank Ag. The firm currently has a buy rating on the stock.

United Internet AG (ETR:UTDI) was given a €57.00 ($67.06) target price by analysts at UBS AG. The firm currently has a buy rating on the stock.

United Internet AG (ETR:UTDI) was given a €56.00 ($65.88) target price by analysts at Kepler Capital Markets. The firm currently has a buy rating on the stock.

Viking Therapeutics (NASDAQ:VKTX) was given a $5.00 price target by analysts at Maxim Group. The firm currently has a buy rating on the stock.

Verastem (NASDAQ:VSTM) was given a $7.00 price target by analysts at HC Wainwright. The firm currently has a buy rating on the stock.

Vuzix Corporation (NASDAQ:VUZI) was given a $11.00 price target by analysts at Maxim Group. The firm currently has a buy rating on the stock.

Wabash National Corporation (NYSE:WNC) had its target price raised by Aegis from $27.00 to $29.00. Aegis currently has a buy rating on the stock.

Xplore Technologies Corp (NASDAQ:XPLR) was given a $4.00 price target by analysts at Maxim Group. The firm currently has a buy rating on the stock.

Zalando SE (FRA:ZAL) was given a €35.00 ($41.18) target price by analysts at UBS AG. The firm currently has a sell rating on the stock.

Zurich Insurance Group AG (VTX:ZURN) was given a CHF 265 price target by analysts at UBS AG. The firm currently has a neutral rating on the stock.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.